Hadlima, Biosimilar to Humira, Receives FDA Approval to Treat Autoimmune Diseases
News
Hadlima (adalimumab-bwwd) — an antibody biosimilar to AbbVie‘s Humira (adalimumab) — has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of a number of autoimmune ... Read more